These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16434397)

  • 1. A pathway of structural changes produced by monastrol binding to Eg5.
    Maliga Z; Xing J; Cheung H; Juszczak LJ; Friedman JM; Rosenfeld SS
    J Biol Chem; 2006 Mar; 281(12):7977-82. PubMed ID: 16434397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monastrol inhibition of the mitotic kinesin Eg5.
    Cochran JC; Gatial JE; Kapoor TM; Gilbert SP
    J Biol Chem; 2005 Apr; 280(13):12658-67. PubMed ID: 15665380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparity in allosteric interactions of monastrol with Eg5 in the presence of ADP and ATP: a difference FT-IR investigation.
    Wojcik EJ; Dalrymple NA; Alford SR; Walker RA; Kim S
    Biochemistry; 2004 Aug; 43(31):9939-49. PubMed ID: 15287721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that monastrol is an allosteric inhibitor of the mitotic kinesin Eg5.
    Maliga Z; Kapoor TM; Mitchison TJ
    Chem Biol; 2002 Sep; 9(9):989-96. PubMed ID: 12323373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the protein binding region of S-trityl-L-cysteine, a new potent inhibitor of the mitotic kinesin Eg5.
    Brier S; Lemaire D; Debonis S; Forest E; Kozielski F
    Biochemistry; 2004 Oct; 43(41):13072-82. PubMed ID: 15476401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of inhibition of human KSP by monastrol: insights from kinetic analysis and the effect of ionic strength on KSP inhibition.
    Luo L; Carson JD; Dhanak D; Jackson JR; Huang PS; Lee Y; Sakowicz R; Copeland RA
    Biochemistry; 2004 Dec; 43(48):15258-66. PubMed ID: 15568818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of the mitotic inhibitor monastrol with human kinesin Eg5.
    DeBonis S; Simorre JP; Crevel I; Lebeau L; Skoufias DA; Blangy A; Ebel C; Gans P; Cross R; Hackney DD; Wade RH; Kozielski F
    Biochemistry; 2003 Jan; 42(2):338-49. PubMed ID: 12525161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dissection of the inhibitor binding pocket of mitotic kinesin Eg5 reveals mutants that confer resistance to antimitotic agents.
    Brier S; Lemaire D; DeBonis S; Forest E; Kozielski F
    J Mol Biol; 2006 Jul; 360(2):360-76. PubMed ID: 16780877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Snapshots" of ispinesib-induced conformational changes in the mitotic kinesin Eg5.
    Kaan HY; Major J; Tkocz K; Kozielski F; Rosenfeld SS
    J Biol Chem; 2013 Jun; 288(25):18588-98. PubMed ID: 23658017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of human Eg5 in complex with a new monastrol-based inhibitor bound in the R configuration.
    Garcia-Saez I; DeBonis S; Lopez R; Trucco F; Rousseau B; Thuéry P; Kozielski F
    J Biol Chem; 2007 Mar; 282(13):9740-9747. PubMed ID: 17251189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structural kinetics of switch-1 and the neck linker explain the functions of kinesin-1 and Eg5.
    Muretta JM; Jun Y; Gross SP; Major J; Thomas DD; Rosenfeld SS
    Proc Natl Acad Sci U S A; 2015 Dec; 112(48):E6606-13. PubMed ID: 26627252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A structural model for monastrol inhibition of dimeric kinesin Eg5.
    Krzysiak TC; Wendt T; Sproul LR; Tittmann P; Gross H; Gilbert SP; Hoenger A
    EMBO J; 2006 May; 25(10):2263-73. PubMed ID: 16642039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the human kinesin Eg5 that confer resistance to monastrol and S-trityl-L-cysteine in tumor derived cell lines.
    Tcherniuk S; van Lis R; Kozielski F; Skoufias DA
    Biochem Pharmacol; 2010 Mar; 79(6):864-72. PubMed ID: 19896928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docking and rolling, a model of how the mitotic motor Eg5 works.
    Rosenfeld SS; Xing J; Jefferson GM; King PH
    J Biol Chem; 2005 Oct; 280(42):35684-95. PubMed ID: 16115880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATPase mechanism of Eg5 in the absence of microtubules: insight into microtubule activation and allosteric inhibition by monastrol.
    Cochran JC; Gilbert SP
    Biochemistry; 2005 Dec; 44(50):16633-48. PubMed ID: 16342954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loop L5 assumes three distinct orientations during the ATPase cycle of the mitotic kinesin Eg5: a transient and time-resolved fluorescence study.
    Muretta JM; Behnke-Parks WM; Major J; Petersen KJ; Goulet A; Moores CA; Thomas DD; Rosenfeld SS
    J Biol Chem; 2013 Nov; 288(48):34839-49. PubMed ID: 24145034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for inhibition of Eg5 by dihydropyrimidines: stereoselectivity of antimitotic inhibitors enastron, dimethylenastron and fluorastrol.
    Kaan HY; Ulaganathan V; Rath O; Prokopcová H; Dallinger D; Kappe CO; Kozielski F
    J Med Chem; 2010 Aug; 53(15):5676-83. PubMed ID: 20597485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loop 5-directed compounds inhibit chimeric kinesin-5 motors: implications for conserved allosteric mechanisms.
    Liu L; Parameswaran S; Liu J; Kim S; Wojcik EJ
    J Biol Chem; 2011 Feb; 286(8):6201-10. PubMed ID: 21127071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of the mitotic spindle kinesin Eg5 reveals a novel conformation of the neck-linker.
    Turner J; Anderson R; Guo J; Beraud C; Fletterick R; Sakowicz R
    J Biol Chem; 2001 Jul; 276(27):25496-502. PubMed ID: 11328809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing spindle assembly mechanisms with monastrol, a small molecule inhibitor of the mitotic kinesin, Eg5.
    Kapoor TM; Mayer TU; Coughlin ML; Mitchison TJ
    J Cell Biol; 2000 Sep; 150(5):975-88. PubMed ID: 10973989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.